Biocon declines on reporting 63% fall in Q4 consolidated net profit
Biocon is currently trading at Rs. 381.70, down by 0.90 points or 0.24% from its previous closing of Rs. 382.60 on the BSE.
The scrip opened at Rs. 378.70 and has touched a high and low of Rs. 396.45 and Rs. 377.20 respectively. So far 346372 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 424.95 on 18-Nov-2025 and a 52 week low of Rs. 317.90 on 12-May-2025.
Last one week high and low of the scrip stood at Rs. 396.45 and Rs. 338.00 respectively. The current market cap of the company is Rs. 62194.23 crore.
The promoters holding in the company stood at 44.91%, while Institutions and Non-Institutions held 31.59% and 23.49% respectively.
Biocon has reported over two-fold jump in its net profit at Rs 51.00 crore for the quarter under review as compared to Rs 21.20 crore for the same quarter in the previous year. However, total income of the company has decreased by 7.36% at Rs 654.50 crore for Q4FY26 as compared to Rs 706.50 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 63.45% fall in its net profit at Rs 125.90 crore for the fourth quarter ended March 31, 2026 as compared to Rs 344.50 crore for the same quarter in the previous year. However, the total income of the company increased by 2.59% at Rs 4,569.10 crore for Q4FY26 as compared to Rs 4,453.90 crore for the corresponding quarter previous year.
For the year ended March 31, 2026, the company has reported 93.89% fall in its net profit at Rs 37.20 crore as compared to Rs 609.30 crore for the previous year. However, the total income of the company has increased by 7.29% at Rs 2,666.10 crore for year under review as compared to Rs 2,484.90 crore for year ended March 31, 2025.
